Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Liver steatosis and fibrosis markers¿ association with cardiovascular and renal damage in Japanese adults: the TMM BirThree cohort study
Toshiya Machida; Taku Obara; Mami Ishikuro; Keiko Murakami; Fumihiko Ueno; Aoi Noda; Tomomi Onuma; Fumiko Matsuzaki; Jun Inoue; Shinichi Kuriyama; Nariyasu Mano;
Ann Hepatol. 2023;28:
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;
Ann Hepatol. 2024;29: